The trial demonstrated that immune responses in children were non-inferior to adults, with a similar safety profile after two standard doses of MVA-BN
The new assay consolidates screening for four major viral threats into a single workflow
The approval comes after a systematic review of published literature
Huwel’s diagnostic solutions leverage open RT-PCR system
It is also approved for?AIDS-related Kaposi sarcoma?after failure of highly active antiretroviral therapy, as well as for HIV-negative adult patients with Kaposi sarcoma
The oral therapy is aimed at adults with chronic spontaneous urticaria (CSU) who do not respond adequately to H1-antihistamines
Under the deal, ViiV Healthcare will issue new shares to Shionogi for $2.125 billion and cancel Pfizer’s holding
India in the Changing Landscape of Life-Sciences Research & Development
The grant will fund ten new J.MD projects over the next three years, targeting multiple global health threats
India’s pharmaceutical sector stands at a pivotal inflection point
Subscribe To Our Newsletter & Stay Updated
